SP100 and Cirrhosis: If this disease is not treated, it might lead to fibrosis, cirrhosis, and its associated complications.<sup>1</sup> Early recognition of this entity and immediate institution of therapy are the primary prognostic modifiers.<sup>2</sup> Anti-nuclear autoantibodies can be used for diagnosis, particularly the anti-gp 210 and anti-Sp100 antibodies.